Intas Pharmaceuticals Limited is a major Indian multinational pharmaceutical company with 11 manufacturing facilities in India, and others in the UK and Mexico. They produce a wide range of formulations, including oral solids, injectables, and biosimilars. They also have facilities for API and intermediate manufacturing, and are known for their quality standards and compliance with global regulations. 

Key aspects of Intas' manufacturing in India:

• Multiple Facilities:

  Intas operates 11 manufacturing facilities in India, along with others in the UK and Mexico. 

• Diverse Product Range:

  Their facilities produce a variety of products, including oral solid doses (OSDs), injectables, and biosimilars, serving various therapeutic areas. 

• API and Intermediate Manufacturing:

  Intas also has dedicated facilities for manufacturing active pharmaceutical ingredients (APIs) and intermediates, ensuring a complete value chain. 

• Global Standards and Approvals:

  Intas' facilities are designed and operated to meet global regulatory standards, including those of the US Food and Drug Administration (FDA